Concepedia

Author

Pauline Schneider

Erasmus MC - Sophia Children’s HospitalORCID

Also Known As

P Schneider, P. Schneider, P.N Schneider, PAULINE SCHNEIDER, Pauline Schneider, Pauline Schneider (706997), Schneider, Pauline

81

Publications

1.7K

Citations

21

H-Index

27

Concepts

All Affiliations

Erasmus MC - Sophia Children’s HospitalPrincess Máxima CenterUniversity of Milano-BicoccaGreat Ormond Street HospitalUniversity College London
PS

About

Pauline Schneider is an author at Erasmus MC - Sophia Children’s Hospital specializing in medicine, hematology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

11

555

2

Cell Biology

7

7

440

3

Immunology

6

6

265

4

Health Sciences

1

1

81

5

Molecular Biology

1

1

37

Pauline Schneider

×

26

Publications

1.5K

Citations

20

H-Index

YearCitations

Gene expression profiling–based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants

Ronald W. Stam, Pauline Schneider, Jill Hagelstein,

Blood

2009

160

Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options

Dominique J. P. M. Stumpel, Pauline Schneider, Eddy H.J. Van Roon,

Blood

2009

152

Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale

Dominique J. P. M. Stumpel, Diana Schotte, Ellen Lange-Turenhout,

Leukemia

2010

107

Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis

Antonio Agraz-Doblás, Clara Bueno, Rachael Bashford-Rogers,

Haematologica

2019

107

The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols.

Martine van Grotel, Jules P.P. Meijerink, H. Berna Beverloo,

PubMed

2006

106

Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants

Emma M. C. Driessen, Eddy H.J. Van Roon, J A P Spijkers-Hagelstein,

Haematologica

2013

103

Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia

Ronald W. Stam, Monique L. den Boer, Pauline Schneider,

Blood

2009

83

Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia

Dominique J. P. M. Stumpel, Pauline Schneider, Lidija Seslija,

Leukemia

2011

81

The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis

P Garrido Castro, Eddy H.J. Van Roon, Sandra S. Pinhanços,

Leukemia

2017

73

Prognostic significance of high-level FLT3 expression in MLL-rearranged infant acute lymphoblastic leukemia

Ronald W. Stam, Pauline Schneider, Paola De Lorenzo,

Blood

2007

69

Page 1